|4Jan 5, 9:01 PM ET

Nardo Christopher J. 4

4 · Dermata Therapeutics, Inc. · Filed Jan 5, 2024

Insider Transaction Report

Form 4
Period: 2024-01-04
Nardo Christopher J.
Senior VP, CDO
Transactions
  • Award

    Stock Option (right to buy

    2024-01-04+50,00050,000 total
    Exercise: $0.61Exp: 2034-01-03Common Stock (50,000 underlying)
Footnotes (1)
  • [F1]The shares underlying the option will vest as to 25% upon the 12 month anniversary of the grant date, and will vest as to 75% in 36 equal monthly installments commencing on the 12 month anniversary of the grant date.

Documents

1 file
  • 4
    section16.xmlPrimary

    PRIMARY DOCUMENT